Apr 07, 2016 13:00 pm UTC| Business
DVEM Offers Broad-Based Access to Growth and Income Potential of Emerging Markets IQDG as Newest Addition to Forward-Looking Quality Dividend Growth Suite of ETFsNEW YORK, April 07, 2016 -- WisdomTree (NASDAQ:WETF), an...
NACD to Help Directors Move Beyond Traditional Approaches to Board Refreshment
Apr 07, 2016 13:00 pm UTC| Business
WASHINGTON, April 07, 2016 -- The National Association of Corporate Directors(NACD), the advocate for the profession of directorship, today announced that the 2016 NACD Blue Ribbon Commission will explore building and...
Apr 07, 2016 12:58 pm UTC| Business
Dublin, April 07, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering. ...
Global RNAi Technologies, Markets and Companies Report 2016
Apr 07, 2016 12:52 pm UTC| Business
Dublin, April 07, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "RNAi - Technologies, Markets and Companies" to their offering. Various...
TSI Healthcare Ranks Number 1 Worldwide in Customer Service
Apr 07, 2016 12:48 pm UTC| Business
CHAPEL HILL, N.C. , April 07, 2016 -- TSI Healthcare, a national leader in the sales and support of customized NextGen® Practice Management and Electronic Health Record solutions, added another accolade to its growing...
Global Drug Delivery in Cancer Report 2016 - Technologies, Markets and Companies 2015-2025
Apr 07, 2016 12:48 pm UTC| Business
Dublin, April 07, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer - Technologies, Markets and Companies" to their offering. ...
Collegium Announces Publication of Data on the Durability of Pain Relief with Xtampza ER
Apr 07, 2016 12:43 pm UTC| Business
CANTON, Mass., April 07, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the publication of an analysis of the duration of effect of Xtampza™ ER administered every 12 hours during the Double-blind...